ARCHIVES

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

Panel Waffles On One Vs. Three Year Intervals For Pap Test, Agrees On when They Should Start

August 1, 1980

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

NCI Advisors Approve Research Network On Screening

August 6, 2010

NCI Contracts: Advisors OK Renewal Of chemoprevention Contracts By DCPC

September 6, 1996

Radio Host, Physician Elmer Huerta Becomes American Cancer Society President.

November 9, 2007

NCI Offers Fellowship Training In Epidemiology & Genetics.

February 18, 2000